82 related articles for article (PubMed ID: 1684441)
21. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia.
Meltzer HY; Sommers AA; Luchins DJ
J Clin Psychopharmacol; 1986 Dec; 6(6):329-38. PubMed ID: 2879856
[TBL] [Abstract][Full Text] [Related]
22. Effect of maprotiline combined with conventional neuroleptics against negative symptoms of chronic schizophrenia.
Yamagami S; Soejima K
Drugs Exp Clin Res; 1989; 15(4):171-6. PubMed ID: 2570687
[TBL] [Abstract][Full Text] [Related]
23. High-dose of multiple antipsychotics and cognitive function in schizophrenia: the effect of dose-reduction.
Kawai N; Yamakawa Y; Baba A; Nemoto K; Tachikawa H; Hori T; Asada T; Iidaka T
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1009-14. PubMed ID: 16644082
[TBL] [Abstract][Full Text] [Related]
24. [Comparative efficacy of bromocriptine, carbamazepine and cyproheptadine with neuroleptics in 24 refractory chronic schizophrenic patients].
Llorca PM; Wolf MA; Lançon C; Bougerol T
Encephale; 1993; 19(5):565-71. PubMed ID: 8306925
[TBL] [Abstract][Full Text] [Related]
25. Clinical correlates of antipsychotic polytherapy in patients with schizophrenia in Singapore.
Sim K; Su A; Chan YH; Shinfuku N; Kua EH; Tan CH
Psychiatry Clin Neurosci; 2004 Jun; 58(3):324-9. PubMed ID: 15149301
[TBL] [Abstract][Full Text] [Related]
26. Low dose bromocriptine: a study of acute effects in chronic mediated schizophrenics.
Cutler NR; Jeste DV; Kaufmann CA; Karoum F; Schran HF; Wyatt RJ
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(2):277-83. PubMed ID: 6146164
[TBL] [Abstract][Full Text] [Related]
27. Use of bromocriptine to prevent puerperal lactation during neuroleptic treatment of chronic schizophrenia.
Wolf R
Pharmacopsychiatry; 1992 Sep; 25(5):240-2. PubMed ID: 1357683
[TBL] [Abstract][Full Text] [Related]
28. Prediction and evaluation criteria in perazine therapy of acute schizophrenics. Pharmacokinetic data.
Breyer-Pfaff U; Brinkschulte M; Rein W; Schied HW; Straube E
Pharmacopsychiatria; 1983 Sep; 16(5):160-5. PubMed ID: 6140695
[TBL] [Abstract][Full Text] [Related]
29. Clinical and EEG studies of zotepine, a thiepine neuroleptic, on schizophrenic patients.
Higashi Y; Momotani Y; Suzuki E; Kaku T
Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):8-11. PubMed ID: 2883687
[TBL] [Abstract][Full Text] [Related]
30. Bromocriptine for "negative" schizophrenia.
Levi-Minzi S; Bermanzohn PC; Siris SG
Compr Psychiatry; 1991; 32(3):210-6. PubMed ID: 1679383
[TBL] [Abstract][Full Text] [Related]
31. Low-dose lamotrigine augmentation therapy improves residual symptoms in treatment-resistant schizophrenia: a report of five cases.
Ohnuma T; Takebayashi Y; Higashiyama R; Shibata N; Arai H
Asia Pac Psychiatry; 2013 Dec; 5(4):336-43. PubMed ID: 24591092
[TBL] [Abstract][Full Text] [Related]
32. Low-dose bromocriptine in neuroleptic-resistant schizophrenia: a pilot study.
Wolf MA; Diener JM; Lajeunesse C; Shriqui CL
Biol Psychiatry; 1992 Jun; 31(11):1166-8. PubMed ID: 1356025
[No Abstract] [Full Text] [Related]
33. Baclofen in the treatment of schizophrenia: a pilot study.
Schöpf J; Hucker H
Pharmakopsychiatr Neuropsychopharmakol; 1977 Mar; 10(2):89-91. PubMed ID: 360234
[TBL] [Abstract][Full Text] [Related]
34. Acute and subchronic effects of low-dose bromocriptine in haloperidol-treated schizophrenics.
Gattaz WF; Rost W; Hübner CK; Bauer K
Biol Psychiatry; 1989 Feb; 25(3):247-55. PubMed ID: 2643996
[TBL] [Abstract][Full Text] [Related]
35. Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia.
Suzuki T; Uchida H; Tanaka KF; Nomura K; Takano H; Tanabe A; Watanabe K; Yagi G; Kashima H
Int J Neuropsychopharmacol; 2004 Jun; 7(2):133-42. PubMed ID: 14741059
[TBL] [Abstract][Full Text] [Related]
36. Symptomatic response to antipsychotics differs between recent onset and recurrent chronic schizophrenic patients.
Hill C; Keks NA; Jackson H; Kulkarni J; Hannah D; Copolov D; Singh B
Aust N Z J Psychiatry; 1992 Sep; 26(3):417-22. PubMed ID: 1358053
[TBL] [Abstract][Full Text] [Related]
37. Bromocriptine therapy in chronic schizophrenia: effects on symptomatology, sleep patterns, and prolactin response to stimulation.
Brambilla F; Scarone S; Pugnetti L; Massironi R; Penati G; Nobile P
Psychiatry Res; 1983 Mar; 8(3):159-69. PubMed ID: 6574535
[TBL] [Abstract][Full Text] [Related]
38. An open clinical trial of fenfluramine in chronic schizophrenia: a pilot study.
Kolakowska T; Gadhvi H; Molyneux S
Int Clin Psychopharmacol; 1987 Jan; 2(1):83-8. PubMed ID: 2889761
[TBL] [Abstract][Full Text] [Related]
39. Adjunctive fluoxetine improves global function in chronic schizophrenia.
Goldman MB; Janecek HM
J Neuropsychiatry Clin Neurosci; 1990; 2(4):429-31. PubMed ID: 1983785
[TBL] [Abstract][Full Text] [Related]
40. Cyproheptadine in treatment-resistant chronic schizophrenics with prior negative response to fluoxetine.
Bacher NM; Sanzone MM; Kaup B
J Clin Psychopharmacol; 1994 Dec; 14(6):424-5. PubMed ID: 7884024
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
